Roland Schüle

7PUBLICATIONS
28CO-AUTHORS
Medical biochemistry - lipidsGlycoconjugatesMolecular targetsBiomolecular modelling and designEpigenetics (incl. genome methylation and epigenomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jan 30, 2025
Mitochondrial KMT9 methylates DLAT to control pyruvate dehydrogenase activity and prostate cancer growth.

Yanhan Jia, Sheng Wang, Sylvia Urban

|Apr 26, 2024
LSD1 inhibition circumvents glucocorticoid-induced muscle wasting of male mice.

Qingshuang Cai, Rajesh Sahu, Vanessa Ueberschlag-Pitiot

|Jan 03, 2024
Structure-guided design of a selective inhibitor of the methyltransferase KMT9 with cellular activity.

Sheng Wang, Sebastian O Klein, Sylvia Urban

|Apr 01, 2020
Nitroreductase-Mediated Release of Inhibitors of Lysine-Specific Demethylase 1 (LSD1) from Prodrugs in Transfected Acute Myeloid Leukaemia Cells.

Eva-Maria Herrlinger, Mirjam Hau, Desiree Melanie Redhaber

|Feb 26, 2020
Depletion of histone methyltransferase KMT9 inhibits lung cancer cell proliferation by inducing non-apoptotic cell death.

Hannah Maria Baumert, Eric Metzger, Matthias Fahrner

|May 08, 2019
KMT9 monomethylates histone H4 lysine 12 and controls proliferation of prostate cancer cells.

Eric Metzger, Sheng Wang, Sylvia Urban

Pageof 2